Coronary Microvascular Dysfunction in Men with Prostate Cancer Receiving Androgen-Deprivation Therapy.

Autor:	Welch, Erin, Guerraty, Marie A., Demissei, Biniyam G., Haas, Naomi, Takvorian, Samuel, Parikh, Ravi B., Vaughn, David J., Pryma, Daniel, Mankoff, David A., Ky, Bonnie, Narayan, Vivek
Předmět:	CARDIOVASCULAR diseases PROSTATE cancer ANDROGENS CARDIOVASCULAR diseases risk factors OVERALL survival HEALTH outcome assessment
Zdroj:	Clinical Genitourinary Cancer; Aug2024, Vol. 22 Issue 4, pN.PAG-N.PAG, 1p
Abstrakt:	• Cardiovascular disease (CVD) is a leading cause of death for men with prostate cancer, and novel methods are needed to measure, monitor, and predict the risk of CVD. • In this report, longitudinal myocardial PET stress imaging was feasible and demonstrated potential clinical utility in the monitoring of subclinical CVD in prostate cancer patients initiating androgen deprivation therapy. • With further study, novel application of this tool in prostate cancer patients receiving androgen deprivation therapy may help inform the monitoring and management of cardiovascular risk. [ABSTRACT FROM AUTHOR]
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu Full Text from ScienceDirect